Thursday, October 30, 2025

Oncology Firm Erasca Eyes US$300 Million IPO

Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market today under the symbol “ERAS”. The firm’s initial public offering is looking to raise US$300.0 million and is expected to close on July 20, 2021.

The offering will be conducted through the issuance of 18,750,000 common shares selling at US$16.00 per share.

The company granted a 30-day over-allotment option to purchase additional 2,812,500 common shares at the same IPO price, potentially bringing proceeds up to US$345.0 million. J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI, and Guggenheim Securities are all acting as joint bookrunners for the said offering.

According to its profile, Erasca is a clinical-stage precision oncology company focused on therapy solutions for RAS/MAPK pathway-driven cancers. The company got its name from its mission statement to “erase cancer”.


Information for this briefing was found via Sedar and Erasca. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Healthcare Reimbursement Firm MSP Recovery To Be Taken Public In A US$32.6 Billion SPAC Merger

Health insurance reimbursement platform MSP Recovery (Nasdaq: MSPR) closed its business combination with special purpose...

Thursday, May 26, 2022, 02:21:00 PM

SoftBank-Backed Chip Designer Arm Files For $70-Billion IPO

Arm, a prominent chip designer under SoftBank’s ownership, has initiated the final countdown to its...

Tuesday, August 22, 2023, 09:53:00 AM

Ripple Plans For Public Debut Following SEC Lawsuit Settlement

Despite an ongoing SEC lawsuit, major cryptocurrency company Ripple has not given up on making...

Friday, April 30, 2021, 02:38:00 PM

SPAC Patria Latin American Opportunity Acquisition Prices US$200 Million IPO

Special purpose acquisition company Patria Latin American Opportunity Acquisition Corp. (Nasdaq: PLAOU) started trading publicly...

Thursday, March 10, 2022, 02:21:00 PM

Biopharma Absci Prices US$200 Million IPO

Synthetic biology company Absci Corporation began trading on the Nasdaq Global Select Market today under...

Thursday, July 22, 2021, 12:43:00 PM